Bonus: Vaccines for dummies with Moderna President Dr. Stephen Hoge

11/24/20 • 52 min

For the last nine months, as the coronavirus swept across the world, devastating so many lives in its wake, scientists have been working around the clock to develop a safe and effective vaccine in record time. And now the results from all of that hard work are starting to come in and it’s good news. Like, really good news. On this bonus episode of Next Question with Katie Couric, Katie talks with Dr. Stephen Hoge, a doctor, scientist and president of Moderna, one of the biotech firms leading the COVID-19 vaccine race. Moderna is remarkable in that it is, compared to the Pfizer behemoths of the world, a tiny biotech firm. But that hasn’t stopped it from cracking the vaccine code using a novel approach. In this wide-ranging interview, Katie and Dr. Hoge talk about the company, the pandemic, and the logistics of these vaccines — who gets them and when. Let’s call it, vaccines for dummies. Enjoy!

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.

Explicit content warning

11/24/20 • 52 min

2 Listeners

Next Question with Katie Couric - Bonus: Vaccines for dummies with Moderna President Dr. Stephen Hoge

Transcript

Speaker 100:00:01.280

I'm Katie Kuric, and welcome to Next Question. For the last nine months, as the coronavirus swept across the world, devastating so many lives in its wake, scientists have been working around the clock to develop a safe and effective vaccine in record time. And now, in just the last few weeks, the result from all of this hard work is starting to come in and it's good news, really good news. Remember what that's like. Fisser has sought emergency us

Bonus: Vaccines for dummies with Moderna President Dr. Stephen Hoge Top Questions Answered

What are the side effects of COVID-19 vaccines?

Vaccine side effects are mostly tolerable, like aches and pains.

Are mRNA vaccines problematic for autoimmune disease?

There is no evidence that mRNA vaccines are problematic for autoimmune disease.

How many participants were involved in vaccine trials?

Vaccine trials had large numbers of participants, showing confidence in safety.

How much money was invested in vaccine development?

Billions of dollars were invested in vaccine development.

Are pregnant women's safety being monitored in relation to COVID-19 vaccines?

Yes, pregnant women's safety is being closely monitored.

Do vaccinated people still get protected against COVID-19?

Vaccinated people are protected against COVID-19, even if others aren't vaccinated.

Have virus mutations affected vaccine protection?

So far, virus mutations have not affected vaccine protection.

Will mRNA technology be useful in fighting future pandemics?

mRNA technology offers flexibility in fighting pandemics.

Were efforts made to increase diversity in vaccine trials?

Yes, efforts were made to increase diversity in vaccine trials.

What are the storage requirements for Moderna's vaccine?

Moderna's vaccine requires standard freezer or refrigerator storage.

Show more Questions

Generate a badge

Get a badge for your website that links back to this episode

Select type & size

Copy